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Background: Because there is little research on the effects of transplanted stem cells on neuronal metabolites in
infarct areas, we transplanted human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) into cerebral
ischemic rabbits and examined the neuronal metabolites.
Results: Rabbits (n = 40) were equally divided into sham, middle cerebral artery occlusion (MCAO), hUCB-MSC, and
saline groups. The rabbit ischemic model was established by MCAO. The effects of hUCB-MSC transplantation were
assessed by proton magnetic resonance spectroscopy (1H-MRS), neurological severity scores (NSSs), infarct area
volume, neuronal density, and optical density (OD) of microtubule-associated protein 2 (MAP2)-positive cells. We
also evaluated complete blood cell counts(CBCs) and serum biochemical parameters. NSSs in the hUCB-MSC group
at 7 and 14 days after reperfusion were lower than in MCAO and saline groups (p < 0.05). Compared with MCAO
and saline groups at 2 weeks after MCAO, the infarction volume in the hUCB-MSC group had decreased remarkably
(p < 0.05). Significant neuronal metabolic changes occurred in the infarct area at 24 h and 2 weeks after MCAO.
1H-MRS revealed an elevation in the lactate (Lac)/creatine including phosphocreatine (Cr) ratio and a decrease in
the N-acetylaspartate (NAA)/Cr and choline-containing phospholipids (Cho)/Cr ratios at 24 h after MCAO in the
MCAO group (p < 0.01). Compared with saline and MCAO groups at 24 h and 2 weeks after MCAO, NAA/Cr and
Cho/Cr ratios had increased significantly, whereas the Lac/Cr ratio had decreased significantly in the hUCB-MSC
group (p < 0.01). Neuronal density and OD of MAP2-positive cells in the MCAO group were significantly lower than
those in the sham group, whereas the neuronal density and OD of MAP2-positive cells in the hUCB-MSC group
were higher than those in MCAO and saline groups (p < 0.05). CBCs and biochemical parameters were unchanged
in the MCAO group at 24 h and 2 weeks after hUCB-MSC transplantation.
Conclusions: Transplanted hUCB-MSCs might ameliorate ischemic damage by influencing neuronal metabolites in
the infarct area, providing additional evidence for neuroprotection by stem cells. No significant changes were
observed in CBCs or serum biochemical parameters, suggesting that intravenous infusion of hUCB-MSCs is safe for
rabbits in the short-term.
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Figure 1 Morphological features of MSCs isolated from hUCB.
Passage 5 hUCB-MSCs subcultured for 7 days. The cells exhibited a
fusiform or fibroblast-like shape, and were arranged as a whirlpool.
Magnification, ×40.
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Cerebral vascular diseases are a major cause of mortality
and disability worldwide. In China, stroke is a leading
cause of death and the most common cause of adult
disability. At least 1,500,000 patients are affected by
cerebrovascular diseases annually, and approximately
30% of these patients become severely and permanently
disabled. Many other survivors are left with permanent
functional impairments [1]. Some interventions during
the acute phase of stroke such as thrombolytic and neuro-
protective agents have been recognized to improve patient
outcomes including survival and residual disability. How-
ever, once cell damage from stroke has been established,
little can be done to restore pre-stroke conditions. In this
regard, hundreds of studies have described the therapeutic
potential of either endogenous or transplanted stem cells
in experimental models of stroke [2]. Therefore, elucida-
tion of potential mechanisms of action is vital to further
develop stem cell therapies for translation to the bedside.
Various proposed mechanisms have been investigated in
preclinical stroke models, including formation of new
neuronal circuitry, reductions of apoptosis and inflam-
mation, and promotion of angiogenesis, neurogenesis,
and other endogenous repair processes [3-6].
Proton magnetic resonance spectroscopy (1H-MRS) is a
non-invasive method to detect various neuronal metabo-
lites in real time, including N-acetylaspartate (NAA), cre-
atine including phosphocreatine (Cr), choline-containing
phospholipids (Cho), and lactate (Lac) [7]. These advances
have led to the emergence of novel approaches to patho-
physiological studies of cerebral ischemia [8]. However,
little has been reported about how transplanted stem cells
might change neuronal metabolites in the infarct area.
Thus, we hypothesized that transplanted stem cells may
ameliorate ischemic damage by influencing neuronal me-
tabolites in the infarct area. To test this hypothesis, we
used a rabbit ischemic model of middle cerebral artery oc-
clusion (MCAO) for transplantation of human umbilical
cord blood mesenchymal stem cells (hUCB-MSCs). We
then assessed neurological severity scores (NSSs), infarct
area volumes, neuronal density, and optical density (OD)
of microtubule-associated protein-2 (MAP2)-positive cells.
NAA, Cr, Cho, and Lac in the infarct region were mea-
sured by 1H- MRS. We also obtained complete blood
cell counts (CBCs) and measured serum biochemical
parameters.Results
Phenotype of hUCB-MSCs
The cells picked from clones could be passaged success-
fully and the cells grew as a fusiform or fibroblast-like
shape, whereas the subclones developed like a whirlpool
(Figure 1).Isolated hUCB-MSCs were characterized by flow cyto-
metric analysis of specific surface antigens. hUCB-MSCs
expressed surface antigens CD29 and CD44, but not
CD34 and CD45, which was consistent with the surface
antigens of bone marrow-derived MSCs (Figure 2).
hUCB-MSC transplantation affects NSSs and the infarct
volume in MCAO rabbits
To evaluate the effect of hUCB-MSCs on neurological def-
icits after MCAO, we measured NSSs. The NSSs in the
hUCB-MSC group at 7 and 14 days after reperfusion were
less than those in MACO and saline groups (p < 0.05)
(Figure 3).
Compared with MCAO and saline groups at 2 weeks
after MCAO, infarct volumes in the hUCB-MSC group
decreased remarkably (p < 0.05) (Figure 4).
hUCB-MSC transplantation affects neuronal metabolites in
MCAO rabbits
To observe the effects of hUCB-MSC transplantation on
neuronal metabolites in the infarct area, 1H-MRS was
used to detect the ratios of NAA/Cr, Cho/Cr ,and Lac/Cr
at 24 h and 2 weeks after MCAO. Significant neuronal
metabolic changes in the infarct area were observed at
24 h and 2 weeks after MCAO (Figure 5). 1H-MRS spectra
showed significant elevation in the Lac/Cr ratio and a
marked decrease in NAA/Cr and Cho/Cr ratios at 24 h
after MCAO in the MCAO group (p < 0.01 versus the
sham group). Compared with saline and MCAO groups at
24 h after MCAO, NAA/Cr and Cho/Cr ratios were sig-
nificantly increased and the Lac/Cr ratio was significantly
decreased in the hUCB-MSC group (p < 0.01) (Figure 6).
Interestingly, at 2 weeks after MCAO, NAA/Cr and Cho/
Cr ratios had increased substantially in the hUCB-MSC
Figure 2 Detection of surface marker expression in hUCB-MSCs by flow cytometry. A, 98.9 ± 1.41% CD44+ cells and 1.2 ± 0.34%CD34+ cells.
B, 98.7 ± 1.31% CD29+ cells and 1.3 ± 0.31% CD45+ cells.
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ably compared with those in saline and MCAO groups
(p < 0.01) (Figure 7).
Distribution and migration of hUCB-MSCs in the injured
brain
To investigate whether transplanted hUCB-MSCs could
migrate to the infarcted brain area, hUCB-MSCs labeled
with 5-bromodeoxyuridine (BrdU) were injected via the
right femoral vein of rabbits in the hUCB-MSC group.
BrdU-positive cells migrated selectively to the infarction
area, which were small with round or oval nuclei con-
taining intensely stained brown chromatin (Figure 8).
hUCB-MSC transplantation affects neuronal density and
OD of MAP2-positive cells in the infarct area
MCAO can cause a complete cerebral infarction as shown
by magnetic resonance imaging (MRI) (Figure 9). Cell
morphology in the sham group was normal with only aFigure 3 Effect of hUCB-MSC transplantation on NSSs in MCAO
rabbits (n = 10, mean ± SE). *p < 0.05 versus the MACO group;
#p < 0.05 versus the saline group.few necrotic cells. More necrotic cells were observed in
MCAO and saline groups (Figure 10). MAP2 immuno-
staining products were localized within the cytodendrites
of brain neurons in the sham group. MAP2 immunolabel-
ing was markedly diminished in the infarct zone, and there
was an abrupt transition between the infarct and adjacent
normal tissue with occasional MAP2-positive cells in
the transition zone (Figure 11). To investigate whether
transplanted hUCB-MSCs could protect neurons, we
examined neuronal density and OD of MAP2-positive
cells in the infarct area. Neuronal density and OD of
MAP2-positive cells in the MCAO group were signifi-
cantly lower than those in the sham group (p < 0.05).
However, neuronal density and OD of MAP2-positive
cells in the hUCB-MSC group was higher than those in
MCAO and saline groups (p < 0.05) (Figures 12 and 13).
These data suggest that extensive neuronal damage oc-
curs after MCAO and hUCB-MSC transplantation can
prevent ischemic damage.Figure 4 Effect of hUCB-MSC transplantation on the infarct
volume in MCAO rabbits (n = 10, mean ± SE). *p < 0.05 versus the
MACO group; #p < 0.05 versus the saline group.
Figure 5 1H-MRS spectra of the various groups. A) 1H-MRS spectra in the sham group had upright steep peaks of NAA and Cho. A Lac peak
was not detected. B) 1H-MRS spectra in the MCAO group revealed a reduction in the NAA peak and distinct upright, steep peaks of Lac were
detected at 24 h after MCAO. C) 1H-MRS spectra in the saline group revealed a reduction in the NAA peak. Similar to the saline group, upright
steep peaks of Lac were detected at 24 h after MCAO. D) 1H-MRS spectra in the hUCB-MSC group at 24 h after MCAO. Compared with MCAO
and saline groups, the NAA peak was higher and the Lac peak was lower.
Figure 6 Effect of hUCB-MSC transplantation on 1H-MRS
parameters at 24 h after MCAO (n = 10, mean ± SE). *p < 0.01
versus the sham group; #p < 0.01 versus MCAO and saline groups.
Figure 7 Effect of hUCB-MSC transplantation on 1H-MRS at
2 weeks after MCAO (n = 10, mean ± SE). *p < 0.01 versus the
sham group; #p < 0.01 versus MCAO and saline groups.
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Figure 8 Representative photomicrographs (×100) of
hUCB-MSCs in the injured brain. BrdU-positive cells were within
the ischemic area.
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biochemical parameters in MCAO rabbits
To investigate the safety of hUCB-MSC transplantation in
rabbits, CBCs and serum biochemical parameters were
measured at 24 h and 2 weeks after MCAO. We found no
influence on CBCs, liver function, renal function, serum
glucose, or serum lipids in MCAO rabbits at 24 h and
2 weeks after transplantation (Tables 1, 2, 3, 4).Figure 9 Representative head MRI of MCAO model rabbits.
At 2 days after MCAO, T2WI revealed a hyperintensity in the area of
the middle cerebral artery. Black arrows indicate the ischemic area.Discussion
Stem cell-based strategies are of particular interest in the
study of neurological diseases because mature brains have
a limited capacity for self-repair. MSCs have great poten-
tial to serve as therapeutic agents for stroke treatment,
because they are easily obtained and can be expanded
rapidly ex vivo for transplantation [9,10]. Transplanted
MSCs in an ischemic region of the rat brain can differenti-
ate into neural cells and promote functional improvement
[11,12]. Furthermore, MSCs can improve neurological def-
icits in stroke patients [13]. hUCB-MSCs have proven to
be more advantageous than bone marrow-derived MSCs
in terms of cell procurement, storage, and transplantation
[14]. Moreover, the number and differentiation ability of
bone marrow-derived MSCs significantly decrease with
age [15]. Thus, hUCB-MSCs are a better candidate for
clinical applications of stem cell-based therapies.
In this study, we confirmed that intravenous infusion of
hUCB-MSCs after transient MCAO in rabbits reduced the
infarction volume, prevented ischemic neuronal damage,
and improved neurological deficits. These results are con-
sistent with previous studies in which beneficial effects
were observed in cerebral ischemic models infused with
MSCs [16-18].
1H-MRS enables serial, non-invasive monitoring of neur-
onal metabolite disturbances in the diseased brain in vivo,
such as Cho, Cr, NAA, and Lac [6]. NAA is located pri-
marily in neuroaxonal tissues. Its presence can be used
to determine neuron numbers and activity. Therefore,
decreased NAA indicates impaired neuronal and/or
axonal function [8]. Cho is a marker of cell reversal and
reflects the stability of cell membranes. Its peak level is
usually related to cell membrane synthesis and catabol-
ism, which depends on the concentrations of Cho in
membrane phospholipids. Cho peaks can reflect the
amount of Cho-containing compounds in the myelin
membrane, such as phosphocholine and glyceropho-
sphocholine. Abnormal Cho peaks can be observed in
pathological conditions such as demyelination, degen-
erative changes, and ischemic states [19]. Lac is a redox
partner of pyruvate and metabolic intermediate between
glycolysis and Kreb’s or the tricarboxylic acid (TCA)
cycle. When oxygen availability is low because of perfu-
sion deficiency or other metabolic stress, the rate of the
TCA cycle decreases and pyruvate produced by glycoly-
sis accumulates and is converted to Lac. Thus, Lac can
serve as a marker of anaerobic metabolism in stroke.
Lac detection by 1H-MRS in vivo may allow identifica-
tion of regions of metabolic stress in the brain and other
human tissues, which can potentially identify regional
ischemia in stroke [20]. Therefore, serial decreases in
NAA/Cr and Cho/Cr ratios and elevations in the Lac/Cr
ratio essentially indicate brain damage. In our current
study, we observed an elevated Lac/Cr ratio and a marked
Figure 10 Representative photomicrographs (×200) of the infarct area. A, sham group; B, MCAO group; C, hUCB-MSC group; D, saline group.
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MCAO in the MCAO group (p < 0.01), which was consist-
ent with previous studies [18,21]. However, after intraven-
ous delivery of hUCB-MSCs, 1H-MRS analysis at 24 h and
2 weeks indicated a significant decrease in the Lac/Cr
ratio and a marked elevation in NAA/Cr and Cho/Cr
ratios compared with those in MCAO and saline groups.
These findings suggest neuroprotection induced by the
transplantation procedure.
MSCs produce an impressive array of neuroprotec-
tive compounds. In a meta-analysis of 60 preclinical
studies of intravenously delivered stem cells, Janowski and
colleagues reported that good patient outcomes were
correlated with inhibition of apoptosis [22]. Neuropro-
tection by the transplantation procedure may be direct
via secretion of neuroprotective compounds or indirect
via immunomodulation, angiogenesis, or amplification
of the endogenous neural stem cell response [23]. In
our present study, hUCB-MSC transplantation restored
the 1H-MRS data to near normal at 2 weeks after MCAO.
Moreover, hUCB-MSC transplantation protected neurons
in the infarct area. Thus, our data may offer additional
supportive evidence for neuroprotection by stem cells.
The safety of stem cell transplantation for treating is-
chemia is important. Short-term concerns include acute
infusional toxicities to important organs, such as hepato-
toxicity and renal toxicity. Long-term concerns includethe risk of tumor formation [24]. In our present study,
no influence was found on CBCs, liver function, renal
function, serum glucose, or serum lipids in MCAO rab-
bits at 24 h and 2 weeks after transplantation.
Conclusions
Taken together, our data show that transplanted hUCB-
MSCs might ameliorate ischemic damage by influencing
neuronal metabolites in the infarct area, which might
offer additional supportive evidence for neuroprotection
by stem cells. No significant changes were observed in
CBCs or serum biochemical parameters, suggesting that




All animal protocols were approved by the Institutional
Animal Care and Use Committee of Clinic College, Anhui
Medical University. Male New Zealand white rabbits (pro-
vided by the Experimental Animal Center of Anhui Medical
University, weighing 2.5–3.5 kg) were randomly divided
into sham (n = 10), MCAO (n = 10), hUCB-MSC (n = 10),
and saline (n = 10) groups. Anesthesia was induced with 2%
sodium pentobarbital (20 mg/kg). The rectal temperature
was maintained at 37°C throughout the surgical procedure
as monitored by an electronic temperature controller linked
Figure 11 Representative photomicrographs (×200) of MAP2 immunohistochemistry. A, sham group; B, MCAO group; C, hUCB-MSC group;
D, saline group.
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MCAO was induced as described previously [25]. Briefly,
the right common carotid artery (CCA), external carotid
artery, and internal carotid artery (ICA) were exposed
through a ventral midline incision. A nylon monofila-
ment suture with a rounded tip (head-end diameter:
0.53 mm) was introduced into the CCA lumen and gently
advanced into the ICA until it blocked the bifurcating ori-
gin of the MCA. At 2 h after occlusion, the rabbits wereFigure 12 Neuronal density (per mm2) among groups (n = 10,
mean ± SE). *p < 0.05 versus the sham group; #p < 0.05 versus
MCAO and saline groups.re-anesthetized and reperfused by withdrawing the suture
until its tip cleared the lumen of the CCA.
hUCB-MSC culture and identification
Ethical approval for the use of hUCB-MSCs was ob-
tained from Clinic College, Anhui Medical University.Figure 13 Optical density of MAP2-positive cells among groups
(n = 10, mean ± SE). *p < 0.05 versus sham controls; #p < 0.05 versus
MCAO and saline groups.






HB (g/L) PLT (109/L)
Sham 7.56 ± 1.40 5.05 ± 0.55 120.50 ± 17.04 241.90 ± 56.58
MCAO 7.74 ± 1.16 5.36 ± 0.73 115.00 ± 14.94 258.00 ± 68.81
hUCB-MSC 7.50 ± 1.30 5.22 ± 0.70 112.10 ± 13.07 281.30 ± 88.51
Saline 7.50 ± 1.92 5.33 ± 0.62 119.60 ± 20.80 240.50 ± 63.31
Note: white blood cells (WBCs); red blood cells (RBCs); hemoglobin (HB);
platelet count (PLT).
Table 3 CBCs of each group at 2 weeks after MCAO





HB (g/L) PLT (109/L)
Sham 7.32 ± 1.28 5.21 ± 0.46 122.52 ± 14.07 245.60 ± 53.21
MCAO 7.57 ± 1.41 5.62 ± 0.23 114.40 ± 13.26 255.00 ± 70.07
hUCB-MSC 7.28 ± 1.08 5.34 ± 0.41 112.06 ± 13.64 277.30 ± 85.65
Saline 7.33 ± 1.15 5.77 ± 0.52 117.63 ± 18.83 270.50 ± 82.77
Note: white blood cells (WBCs); red blood cells (RBCs); hemoglobin (HB);
platelet count (PLT).
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the umbilical vein of full-term infants during deliveries
with informed maternal consent. Isolation and expansion
of hUCB-MSCs was conducted as reported previously
[26]. Briefly, mononuclear cells were isolated by density
gradient centrifugation. The separated mononuclear cells
were washed, resuspended in Dulbecco’s modified Eagle’s
medium, and then seeded at 1 × 106 cells/mL. Cultures
were maintained at 37°C in a humidified atmosphere
containing 5% CO2, and the culture medium was chan-
ged twice a week. Fibroblast-like adherent cells were
observed in UCB-derived mononuclear cell cultures.
After 1 –3 weeks, MSC colonies reached 80% conflu-
ence and the cells were trypsinized (0.25% trypsin),
washed, resuspended in culture medium, and subcul-
tured at 5 × 104 cells/cm2. MSCs of each hUCB harvest
were expanded ex vivo by successive subcultivation
under the same conditions. Passage 5–8 cells with a
more than 1,000-fold expanding capacity were used in
experiments.
Isolated hUCB-MSCs were characterized by flow cyto-
metric analysis of specific surface antigens using CD29-
FITC, CD45-PE, CD44-FITC, and CD34-PE monoclonal
antibodies (BD Bioscience, San Jose, CA, USA). The
cells were incubated in the dark at room temperature
for 20 min.Table 2 Serum biochemistry of each group at 24 h after
MCAO (n = 10, mean ± SE)
Sham MCAO hUCB-MSC Saline
ALT (U/L) 88.30 ± 24.74 85.20 ± 22.95 95.40 ± 22.20 88.80 ± 17.93
AST (U/L) 90.50 ± 6.85 95.20 ± 18.82 95.40 ± 18.39 90.00 ± 15.89
Urea
(mmol/L)
5.93 ± 1.03 6.06 ± 0.95 5.68 ± 1.26 5.65 ± 1.03
Cr (μmol/L) 90.20 ± 24.89 86.50 ± 12.87 92.10 ± 14.43 94.70 ± 11.69
TG
(mmol/L)
0.84 ± 0.24 1.11 ± 0.81 1.18 ± 0.83 1.26 ± 1.12
Chol
(mmol/L)
1.89 ± 0.75 1.57 ± 0.83 1.50 ± 0.74 1.74 ± 0.57
Glu (mmol/L) 8.07 ± 0.91 7.98 ± 0.85 8.44 ± 1.35 8.41 ± 1.47
Note: aspartatenine aminotransferase (ALT); aspartate aminotransferase (AST).Labeling of hUCB-MSCs with BrdU and tracing BrdU-
positive cells in the injured brain
hUCB-MSCs at passage 5 were cultured in complete
growth medium under the same conditions described
above. Cells were labeled by incubation in medium con-
taining 5 mmol/L BrdU (Roche Diagnostics, Mannheim,
Germany) for 48 h before harvest. BrdU was added ac-
cording to the manufacturer’s instructions. BrdU binds
to DNA and labels the nucleus, serving as a tracer for
in vivo studies of transplanted cells. The distribution of
BrdU-positive cells was detected by immunohistochemical
methods [27]. After 2 weeks, serial sections (6 μm thick)
through the ischemic cortex were prepared from each
rabbit. The sections were then incubated with a primary
anti-BrdU monoclonal antibody (1:500) and then pero
xidase-conjugated anti-rabbit IgG as the secondary anti-
body (1:100). The cells were stained with diaminobenzi-
dine as the chromagen.
hUCB-MSC transplantation
Passage 5 hUCB-MSCs were injected intravenously within
several minutes after MCAO. hUCB-MSCs (5 × 106)
diluted in 2 mL PBS were injected slowly for 5 min via
the right leg femoral vein. For the saline group, 2 mL
PBS without hUCB-MSCs was injected in the same
manner.Table 4 Serum biochemistry of each group at 2 weeks
after MCAO (n = 10, mean ± SE)
Sham MACO hUCB-MSC Saline
ALT (U/L) 78.40 ± 21.12 82.50 ± 24.05 88.80 ± 23.36 90.50 ± 19.34
AST(U/L) 89.60 ± 16.75 91.70 ± 18.52 92.40 ± 17.45 92.20 ± 15.79
Urea
(mmol/L)
5.71 ± 1.05 5.56 ± 0.87 5.78 ± 1.03 5.47 ± 0.76
Cr (μmol/L) 87.20 ± 15.43 89.86 ± 15.34 90.70 ± 14.23 92.40 ± 13.64
TG (mmol/L) 0.75 ± 0.17 1.25 ± 0.61 1.27 ± 0.47 1.04 ± 0.26
Chol
(mmol/L)
1.76 ± 0.86 1.79 ± 0.45 1.67 ± 0.38 1.58 ± 0.62
Glu (mmol/L) 7.47. ± 0.91 8.03 ± 0.25 8.23 ± 1.27 7.61 ± 0.83
Note: aspartatenine aminotransferase (ALT); aspartate aminotransferase (AST).
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Neurological deficits were measured in an independent
and blinded fashion by NSSs as described by Purdy [28].
NSSs include motor function, consciousness, head turn-
ing, circling, and hemianopsia. The minimum NSS is 2,
which is normal, and the maximal NSS is 11, indicating
a comatose or dead animal. NSSs were measured at 6 h,
7 days, and 14 days after hUCB-MSC transplantation.
1H-MRS examination
1H-MRS data were obtained using a 1.5 Tesla MR ma-
chine (Siemens 1.5 T Novus MR scanner) and the point
resolved echo spectroscopy method for localization and
5 mm × 5 mm× 5 mm volume of interest of the hippo-
campus in the bilateral temporal lobe. TE, TR, and NEX
were 18, 400, and 200 ms, respectively. The 1H-MRS de-
tection technology used was multi-voxel spectroscopy
sequence of fixed-point resolution data acquisition. All
spectral data were automatically processed in probe se-
quence on the MR console. Probe acquisition protocols
employed in this study included ratio frequency trans-
mitter receiver gain adjustment, water suppression,
auto-shim process, and data acquisition. The area of
the peak for each organic compound and its compara-
tive value were obtained for each volume of interest. Four
major peaks were measured individually and determined
to be Cho (3.2 ppm), Cr (3.0 ppm), NAA (2.0 ppm), and
Lac (1.3 ppm), which were measured individually. Peak
areas were expressed as the relative ratio to Cr in each
spectrum. Cr was used as the reference because of its rela-
tive stability, even under rapid energy metabolism fluctua-
tions [29]. Infarct volumes were automatically calculated
with Tools Free-hand ROI software (Siemens).Two neuro-
radiologists analyzed all 1H-MRS and MRI data.
Histopathological studies
At 2 weeks after MCAO, all rabbits were anesthetized
with 20% urethane and then their brains were quickly
removed and fixed with 10% formalin. After 24 h, the
tissues were embedded in paraffin and serial sections
(6 μm thick) were prepared through the ischemic cortex.
The sections were then stained with hematoxylin and
eosin. Neurons in a linear length (1 mm) were counted
under a light microscope.
MAP2 immunohistochemistry
The sections were dewaxed with a standard procedure
and washed with PBS as described previously [30]. Briefly,
after blocking in 10% normal goat serum/PBS for 30 min
at room temperature, the sections were incubated with a
mouse anti-MAP-2 polyclonal antibody (1:200, Santa Cruz
Biotechnology, Santa Cruz, CA, USA) for 16 h at 4°C.
After three washes in PBS (10 min each), the sections were
incubated with a goat anti-mouse secondary antibody for2 h at room temperature. The sections were washed as de-
scribed above and then incubated with an avidin biotinyl-
ated enzyme complex for 1 h at room temperature. The
sections were visualized with diaminobenzidine. Nuclei
were counterstained with hematoxylin. Finally, the sec-
tions were dehydrated in an alcohol gradient and
cleared with xylene. Ten images were then randomly
captured in microscopic fields for each group. The im-
ages were used to analyze the OD of MAP2-positive
cells with JEDA 801D software (Jiangsu JEDA Science
Technology Development, China).
Statistical analysis
All data were expressed as the means ± standard error
(SE). The Student’s t-test was used to compare differ-
ences between two groups. One-way analysis of variance
was used to determine the significance of differences
among multiple comparisons. Statistical significance was
set at p < 0.05.
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